Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report

BACKGROUND: Pseudoprogression, the initial apparent worsening of cancer prior to eventual improvement, is a documented feature of immune checkpoint inhibitor administration and presents a challenge to clinicians distinguishing true progression from pseudoprogression. This phenomenon does not typical...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonugunta, Amrit S., von Itzstein, Mitchell S., Gerber, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310470/
https://www.ncbi.nlm.nih.gov/pubmed/35871685
http://dx.doi.org/10.1186/s13256-022-03485-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310470/
https://www.ncbi.nlm.nih.gov/pubmed/35871685
http://dx.doi.org/10.1186/s13256-022-03485-6

Ejemplares similares